South University School of Pharmacy, Columbia, South Carolina.
Am J Pharm Educ. 2020 Oct;84(10):ajpe8136. doi: 10.5688/ajpe8136.
The number of applicants to US pharmacy schools has been declining since 2013, leading to a national enrollment crisis. Enrollment challenges threaten the viability of many pharmacy programs. Some schools are better equipped than others to confront the risk of having to downsize or close, creating survival-of-the-fittest conditions. Four potential risk factors have been identified based on how applicants might perceive the comparable value of respective programs. Schools with lower risk are public, established before 2000, located within an academic health center, and traditional (ie, four-year) programs. The Academy cannot sustain more than 140 schools much longer. Market forces are establishing a new equilibrium between the number of graduates and the availability of pharmacist jobs. As more jobs become available, more applicants will apply. Until then, the fittest Doctor of Pharmacy programs will thrive, while others might have to downsize to survive, and the weakest will be at risk of extinction.
自 2013 年以来，申请进入美国药学院校的人数一直在下降，导致全国招生危机。招生挑战威胁到许多药学项目的生存能力。一些学校比其他学校更有能力应对不得不缩小规模或关闭的风险，从而创造了适者生存的条件。根据申请人如何看待各自项目的相对价值，确定了四个潜在的风险因素。风险较低的学校是公立学校、成立于 2000 年之前、位于学术医疗中心内以及传统（即四年制）项目。药学院校联合会不能再维持 140 多所学校更长时间了。市场力量正在毕业生人数和药剂师工作岗位数量之间建立新的平衡。随着更多的工作机会出现，将有更多的申请人申请。在此之前，适应性最强的药学博士项目将蓬勃发展，而其他项目可能不得不缩小规模以维持生存，而最弱的项目则面临灭绝的风险。
